Guochun Cao

机构：Jiangsu Cancer Hospital, Nanjing Medical University

发表论文 40 篇 · 总被引 720 次 · h-index 10

代表论文

• PMA1-containing extracellular vesicles of Candida albicans triggers immune responses and colitis progression (2025 · Gut Microbes · 被引 16)
• Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 study (2024 · EClinicalMedicine · 被引 10)
• Neoadjuvant PD-1 Plus Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (2024 · Technology in Cancer Research & Treatment · 被引 6)
• Two cycles versus four cycles of neoadjuvant camrelizumab plus chemotherapy in patients with locally advanced esophageal squamous cell carcinoma (ESCC): A prospective, multicenter and randomized study. (2023 · Journal of Clinical Oncology · 被引 4)
• Polymeric Micellar Paclitaxel Plus Cisplatin Combined With Tislelizumab as the First‐Line Treatment of Advanced Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Study (2025 · Thoracic Cancer · 被引 3)
• CircATXN7 regulates the proliferation and invasion of esophageal cancer cells through miR-4319/NLRC5 (2024 · Cellular Signalling · 被引 2)